Page last updated: 2024-08-18

chalcone and Stroke

chalcone has been researched along with Stroke in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Cai, YF; Fan, LL; Fang, H; Lu, FM; Ma, HH; Qiao, LJ; Su, S; Wan, C; Wen, JR; Wu, GL; Zhang, C; Zhang, SJ; Zhou, ZY1
Cao, X; Chen, H; Duan, Y; He, W; Lai, Z; Liu, Z; Tao, J; Xu, C; Yu, L; Zhang, J; Zhang, Q; Zhao, Z1
Cai, YF; Gao, M; Hu, MZ; Li, L; Lin, AJ; Liu, LM; Lu, H; Song, HQ; Wang, X; Wu, QM; Zhou, HF; Zhou, ZY1
Cui, Q; Ge, SQ; Ma, YH; Qin, XD; Yu, HY; Zhang, GW; Zhang, YL1
Cai, B; Chen, YL; Hu, BH; Liu, JG; Liu, X; Lu, M; Qin, Z; Sun, Y; Wang, PY; Xu, DP; Yu, JG; Zhao, Y1
Cui, L; Fan, S; Lin, N; Shan, G; Zuo, P1
Dong, W; Ji, X; Liu, KJ; Luo, Y; Qi, Z; Shen, J; Shi, W; Yan, F; Zhang, C; Zhao, Y1
Fu, FH; Li, CL; Liu, K; Tian, JW; Wang, ZH; Zhang, L; Zhu, HB1
Baba, K; Kamisako, T; Ogawa, H; Okada, Y1

Reviews

1 review(s) available for chalcone and Stroke

ArticleYear
Safflower yellow for acute ischemic stroke: A systematic review of randomized controlled trials.
    Complementary therapies in medicine, 2014, Volume: 22, Issue:2

    Topics: Chalcone; Humans; Randomized Controlled Trials as Topic; Stroke

2014

Trials

1 trial(s) available for chalcone and Stroke

ArticleYear
Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
    Chinese journal of integrative medicine, 2020, Volume: 26, Issue:6

    Topics: Aged; Brain Ischemia; Cerebrovascular Circulation; Chalcone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections; Male; Middle Aged; Quinones; Stroke; Surveys and Questionnaires

2020

Other Studies

7 other study(ies) available for chalcone and Stroke

ArticleYear
Hydroxysafflor Yellow A Exerts Neuroprotective Effect by Reducing Aβ Toxicity Through Inhibiting Endoplasmic Reticulum Stress in Oxygen-Glucose Deprivation/Reperfusion Cell Model.
    Rejuvenation research, 2023, Volume: 26, Issue:2

    Topics: Amyloid Precursor Protein Secretases; Apoptosis; Aspartic Acid Endopeptidases; Chalcone; Endoplasmic Reticulum Stress; Glucose; Humans; Neuroblastoma; Neuroprotective Agents; Oxygen; Quinones; Reperfusion; Reperfusion Injury; Stroke

2023
Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways.
    Cellular and molecular neurobiology, 2020, Volume: 40, Issue:8

    Topics: Animals; Brain Ischemia; Chalcone; Janus Kinase 2; Male; Neurons; Neuroprotection; Quinones; Stroke; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins

2020
Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.
    European journal of pharmacology, 2021, Oct-05, Volume: 908

    Topics: Animals; Chalcone; Quinones; Rats; Stroke

2021
Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke.
    European journal of pharmacology, 2018, Jan-05, Volume: 818

    Topics: Animals; Basilar Artery; Blood Pressure; Blood Viscosity; Brain; Brain Ischemia; Cerebrovascular Circulation; Chalcone; Coronary Vessels; Dogs; Heart Rate; Permeability; Platelet Aggregation; Quinones; Rabbits; Rats; Stroke; Thrombosis; Vasodilation

2018
AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats.
    Translational stroke research, 2014, Volume: 5, Issue:4

    Topics: Animals; Autophagy; Brain; Brain Ischemia; Chalcone; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Quinones; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke

2014
Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
    Journal of Asian natural products research, 2005, Volume: 7, Issue:4

    Topics: Animals; Brain Ischemia; Chalcone; Dose-Response Relationship, Drug; Epoprostenol; Infarction, Middle Cerebral Artery; Quinones; Rats; Stroke

2005
Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:3

    Topics: Angelica; Animals; Apolipoproteins; Blood Pressure; Chalcone; Diet; Enzyme Inhibitors; Feces; Glucose; Lipid Metabolism; Lipids; Lipoproteins; Liver; Plant Stems; Rats; Rats, Inbred SHR; Stroke

2007